Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-12-20
2005-12-20
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S034000, C514S049000, C514S256000, C514S283000
Reexamination Certificate
active
06977247
ABSTRACT:
A method is provided for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising: administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient; and administering a pyrimidine base analog to the patient.
REFERENCES:
patent: 5225404 (1993-07-01), Giovannella et al.
patent: 5573781 (1996-11-01), Brown et al.
patent: 5786344 (1998-07-01), Ratain et al.
patent: 6166029 (2000-12-01), Giovanella et al.
patent: 6191119 (2001-02-01), Rubinfeld
patent: 6342487 (2002-01-01), Riou et al.
patent: 6403569 (2002-06-01), Achterrath
Bernacki et al., “In Vitro Antitumor Activity of 9-Nitro-Camptothecin as a Single Agent and in Combination with other Antitumor Drugs”, Annals of the New York Academy of Sciences, vol. 922, pp. 293-297, 2000.
Devita, V., et al., Cancer: Principles and Practice of Onocology, (1997) 5thEdition, pp. 335-337.
Lee, J.H. et al., Antitumor Activity of 7-[2-(N-Isopropylamino)ethyl]-(20S)-Campthothecin, CKD602, as a Potent DNA Topoisomerase I Inhibitor,Arch Pharm Res. (1998), vol., 21, No. 5, pp. 581-589.
Luzzio, M.J. et al., Synthesis And Antitumor Acitvity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I,Journal of Medicinal Chemistry(1995), vol. 38, No. 3, pp. 395-401.
Wall, M.E. et al., Plant Antitumor Agents. 30.1a,bSynthesis And Structure Activity of Novel Camptothecin Analogs,J Med. Chem(1993) vol. 36, No. 18, pp. 2689-2700.
Lyons John
Mettinger Karl L.
Romel Lawrence A.
Rubinfeld Joseph
Chen Shirley
McIntosh III Traviss C.
SuperGen, Inc.
Wilson James O.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Sequential therapy comprising a 20(S)-camptothecin and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequential therapy comprising a 20(S)-camptothecin and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequential therapy comprising a 20(S)-camptothecin and a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3475163